Response to Hyun J.W. et al. “Longitudinal analysis of serum neurofilament light chain: A potential therapeutic monitoring biomarker for multiple sclerosis”
Restricted accessLetterFirst published online May, 2020
Response to Hyun J.W. et al. “Longitudinal analysis of serum neurofilament light chain: A potential therapeutic monitoring biomarker for multiple sclerosis”
HyunJWKimYKimG, et al. Longitudinal analysis of serum neurofilament light chain: A potential therapeutic monitoring biomarker for multiple sclerosis. Mult Scler2020; 26(6): 659–667.
2.
DisantoGBarroCBenkertP, et al. Serum neurofilament light: A biomarker of neuronal damage in multiple sclerosis. Ann Neurol2017; 81: 857–870.
3.
KuhleJKropshoferHHaeringDA, et al. Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. Neurology. Epub ahead of print 8 February 2019. DOI: 10.1212/WNL.0000000000007032.
4.
AkgünKKretschmannNHaaseR, et al. Profiling individual clinical responses by high-frequency serum neurofilament assessment in MS. Neurol Neuroimmunol Neuroinflamm. Epub ahead of print 8 April 2019. DOI: 10.1212/NXI.0000000000000555.
